to : 15 March 2019
TransCure bioServices will give a pitch at the 3rd Annual Next-Gen Immuno-Oncology Congress
TransCure bioServices gives a pitch
Attend the pitch of Sebastien Tabruyn at 3.30 pm on March 14th.
Topic of Presentation (with 3 bullet points):
- Humanized Mouse Models for Immuno-oncology Research
- Preclinical Oncolytic Virus Efficacy Testing
- Immune check point inhibitor: How to validate combination therapy
- Preclinical Immunotherapy Safety and Toxicity Assessment: Case study with CAR-T cells
Meet our Director, Business Development and CSO by requesting a meeting:
Who are we?
TransCure bioService is a pre-clinical CRO dedicated to the evaluation of treatments for HIV, immuno-oncology, and inflammations diseases. Our team elaborates unique Research & Development (R&D) and fee-for-service platforms, called the Full Human Immune System Mouse Models (hu-mouse models). Therefore, customers access these full services (protocol design, data collection and analysis) in our BSL-2 and BSL-3 animal and laboratory facilities on a very attractive fee-for-service basis.
Request a meeting with our Team in London